Outcomes predictors in endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stent: Systematic review and meta-analysis.

IF 2.2 Q3 GASTROENTEROLOGY & HEPATOLOGY
Endoscopy International Open Pub Date : 2024-03-28 eCollection Date: 2024-03-01 DOI:10.1055/a-2271-2145
Alessandro Fugazza, Kareem Khalaf, Marco Spadaccini, Antonio Facciorusso, Matteo Colombo, Marta Andreozzi, Silvia Carrara, Cecilia Binda, Carlo Fabbri, Andrea Anderloni, Cesare Hassan, Todd Baron, Alessandro Repici
{"title":"Outcomes predictors in endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stent: Systematic review and meta-analysis.","authors":"Alessandro Fugazza, Kareem Khalaf, Marco Spadaccini, Antonio Facciorusso, Matteo Colombo, Marta Andreozzi, Silvia Carrara, Cecilia Binda, Carlo Fabbri, Andrea Anderloni, Cesare Hassan, Todd Baron, Alessandro Repici","doi":"10.1055/a-2271-2145","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background and study aims</b> EUS-guided choledochoduodenostomy (EUS-CDS) is a minimally invasive procedure used to treat malignant biliary obstruction (MBO) by transduodenal placement of a lumen-apposing metal stent (LAMS) into the extrahepatic bile duct. To identify factors that contribute to safe and effective EUS-CDS using LAMS, we performed a systematic review of the literature and meta-analysis. <b>Methods</b> The methodology of our analysis was based on PRISMA recommendations. Electronic databases (Medline, Scopus, EMBASE) were searched up to November 2022. Full articles that included patients with distal malignant biliary obstruction who underwent EUS-CDS using LAMS after failed endoscopic retrograde cholangiopancreatography were eligible. Random-effect meta-analysis was performed reporting pooled rates of technical success, clinical success, and adverse events (AEs) by means of a random model. Multivariate meta-regression and subgroup analysis were performed to assess possible associations between the outcomes and selected variables to assess the correlation between outcomes and different variables. Results were also stratified according to stent size. <b>Results</b> Twelve studies with 845 patients were included in the meta-analysis. Pooled technical and clinical success rates were 96% (95% confidence interval [CI] 94%-98%; I <sup>2</sup> = 52.29%) and 96% (95%CI 95%-98%), respectively, with no significant association with baseline characteristics, such are sex, age, common bile duct diameter, or stent size. The pooled AE rate was 12% (95%CI: 8%-16%; I <sup>2</sup> = 71.62%). The AE rate was significantly lower when using an 8 × 8 mm stent as compared with a 6 × 8 mm LAMS (odds ratio 0.59, 0.35-0.99; <i>P</i> = 0.04), with no evidence of heterogeneity (I <sup>2</sup> = 0%). <b>Conclusions</b> EUS-CDS with LAMS is a safe and effective option for relief of MBO. Selecting an appropriate stent size is crucial for achieving optimal safety outcomes.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"12 3","pages":"E456-E462"},"PeriodicalIF":2.2000,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10978093/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endoscopy International Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2271-2145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and study aims EUS-guided choledochoduodenostomy (EUS-CDS) is a minimally invasive procedure used to treat malignant biliary obstruction (MBO) by transduodenal placement of a lumen-apposing metal stent (LAMS) into the extrahepatic bile duct. To identify factors that contribute to safe and effective EUS-CDS using LAMS, we performed a systematic review of the literature and meta-analysis. Methods The methodology of our analysis was based on PRISMA recommendations. Electronic databases (Medline, Scopus, EMBASE) were searched up to November 2022. Full articles that included patients with distal malignant biliary obstruction who underwent EUS-CDS using LAMS after failed endoscopic retrograde cholangiopancreatography were eligible. Random-effect meta-analysis was performed reporting pooled rates of technical success, clinical success, and adverse events (AEs) by means of a random model. Multivariate meta-regression and subgroup analysis were performed to assess possible associations between the outcomes and selected variables to assess the correlation between outcomes and different variables. Results were also stratified according to stent size. Results Twelve studies with 845 patients were included in the meta-analysis. Pooled technical and clinical success rates were 96% (95% confidence interval [CI] 94%-98%; I 2 = 52.29%) and 96% (95%CI 95%-98%), respectively, with no significant association with baseline characteristics, such are sex, age, common bile duct diameter, or stent size. The pooled AE rate was 12% (95%CI: 8%-16%; I 2 = 71.62%). The AE rate was significantly lower when using an 8 × 8 mm stent as compared with a 6 × 8 mm LAMS (odds ratio 0.59, 0.35-0.99; P = 0.04), with no evidence of heterogeneity (I 2 = 0%). Conclusions EUS-CDS with LAMS is a safe and effective option for relief of MBO. Selecting an appropriate stent size is crucial for achieving optimal safety outcomes.

内镜超声引导胆总管十二指肠造口术与腔镜贴合金属支架的疗效预测因素:系统回顾和荟萃分析。
背景和研究目的 EUS 引导下胆总管十二指肠造口术(EUS-CDS)是一种微创手术,通过经十二指肠将管腔贴合金属支架(LAMS)置入肝外胆管来治疗恶性胆道梗阻(MBO)。为了确定有助于使用 LAMS 安全有效地进行 EUS-CDS 的因素,我们对文献进行了系统性回顾和荟萃分析。方法 我们的分析方法基于 PRISMA 建议。检索了截至 2022 年 11 月的电子数据库(Medline、Scopus、EMBASE)。符合条件的文章包括在内镜逆行胰胆管造影术失败后使用 LAMS 进行 EUS-CDS 的远端恶性胆道梗阻患者。通过随机模型进行随机效应荟萃分析,报告技术成功率、临床成功率和不良事件(AEs)的汇总情况。进行了多变量荟萃回归和亚组分析,以评估结果与所选变量之间可能存在的关联,从而评估结果与不同变量之间的相关性。研究结果还根据支架大小进行了分层。结果 共有12项研究、845名患者参与了荟萃分析。汇总的技术成功率和临床成功率分别为 96%(95% 置信区间 [CI] 94%-98%;I 2 = 52.29%)和 96%(95%CI 95%-98%),与基线特征(如性别、年龄、胆总管直径或支架大小)无显著关联。汇总的AE率为12%(95%CI:8%-16%;I 2 = 71.62%)。与 6 × 8 mm LAMS 相比,使用 8 × 8 mm 支架的 AE 率明显降低(几率比 0.59,0.35-0.99;P = 0.04),无证据表明存在异质性(I 2 = 0%)。结论 使用 LAMS 的 EUS-CDS 是缓解 MBO 的一种安全有效的选择。选择合适的支架尺寸对于获得最佳安全结果至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endoscopy International Open
Endoscopy International Open GASTROENTEROLOGY & HEPATOLOGY-
自引率
3.80%
发文量
270
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信